The metabolism of antipyrine was studied in 13 patients with cancer and bladder papillomas and in 11 control subjects, matched for interfering factors like smoking, diet, age and sex. The mean antipyrine half-life was significantly longer in patients with urinary tract cancer (14.7 +/- 1.32 h SE) than in control subjects (11 +/- 0.55 h SE) (P less than 0.025); other clinical parameters did not vary
Impairment of antipyrine metabolism in urinary tract cancer / M Ludovici; P Dolara ; A Costantini; G Barbagli; A Calzolai ; N Stomaci.. - In: TUMORI. - ISSN 0300-8916. - STAMPA. - 69:(1983), pp. 221-222.
Impairment of antipyrine metabolism in urinary tract cancer.
LODOVICI, MAURA;DOLARA, PIERO;
1983
Abstract
The metabolism of antipyrine was studied in 13 patients with cancer and bladder papillomas and in 11 control subjects, matched for interfering factors like smoking, diet, age and sex. The mean antipyrine half-life was significantly longer in patients with urinary tract cancer (14.7 +/- 1.32 h SE) than in control subjects (11 +/- 0.55 h SE) (P less than 0.025); other clinical parameters did not vary
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
